Super-SILAC allows Classification of Diffuse Large B-cell ...

REFERENCES
1. Quackenbush, J. (2006) Microarray Analysis and Tumor Classification. New England Journal of
Medicine 354, 2463-2472.
2. McDermott, U., Downing, J. R., and Stratton, M. R. (2011) Genomics and the Continuum of
Cancer Care. New England Journal of Medicine 364, 340-350.
3. Hanash, S., and Taguchi, A. (2010) The grand challenge to decipher the cancer proteome. Nat
Rev Cancer 10, 652-660.
4. Choudhary, C., and Mann, M. (2010) Decoding signalling networks by mass spectrometry-based
proteomics. Nat Rev Mol Cell Biol 11, 427-439.
5. Aebersold, R., and Mann, M. (2003) Mass spectrometry-based proteomics. Nature 422, 198-207.
6. Nilsson, T., Mann, M., Aebersold, R., Yates, J. R., Bairoch, A., and Bergeron, J. J. M. (2010) Mass
spectrometry in high-throughput proteomics: ready for the big time. Nat Meth 7, 681-685.
7. Cox, J., and Mann, M. (2011) Quantitative, high-resolution proteomics for data-driven systems
biology. Annual review of biochemistry 80, 273-299.
8. Vermeulen, M., and Selbach, M. (2009) Quantitative proteomics: a tool to assess cell
differentiation. Current Opinion in Cell Biology 21, 761-766.
9. Mallick, P., and Kuster, B. (2010) Proteomics: a pragmatic perspective. Nat Biotech 28, 695-709.
10. Ong, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M.
(2002) Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach
to Expression Proteomics. Molecular & Cellular Proteomics 1, 376-386.
11. Mann, M. (2006) Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 7,
952-958.
12. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R., and Mann, M. (2010) Super-SILAC mix for
quantitative proteomics of human tumor tissue. Nat Meth 7, 383-385.
13. Geiger, T., Wisniewski, J. R., Cox, J., Zanivan, S., Kruger, M., Ishihama, Y., and Mann, M. (2011)
Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative
proteomics. Nat Protoc 6, 147-157.
14. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet,
H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Lu, L., Lewis, D. B., Tibshirani,
R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Levy, R.,
Wilson, W., Grever, M. R., Byrd, J. C., Botstein, D., Brown, P. O., and Staudt, L. M. (2000) Distinct types of
diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511.
15. Davis, R. E., Brown, K. D., Siebenlist, U., and Staudt, L. M. (2001) Constitutive nuclear factor
kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp
Med 194, 1861-1874.
16. Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy,
L., Zhao, H., Yang, Y., Xu, W., Shaffer, A. L., Wright, G., Xiao, W., Powell, J., Jiang, J. K., Thomas, C. J .,
Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Connors, J. M., Johnson, N. A., Rimsza,
L. M., Campo, E., Jaffe, E. S., Wilson, W. H., Delabie, J., Smeland, E. B., Fisher, R. I., Braziel, R. M., Tubbs,
R. R., Cook, J. R., Weisenburger, D. D., Chan, W. C., Pierce, S. K., and Staudt, L. M. (2010) Chronic active
B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88-92.
17. Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J.,
and Staudt, L. M. (2006) A loss-of-function RNA interference screen for molecular targets in cancer.
Nature 441, 106-110.
[20]